Bidisomide
Grundinformationen
- CAS
116078-65-0- Standard-SMILES
CC(=O)N(CCC(CCN1CCCCC1)(C(N)=O)c1ccccc1Cl)C(C)C- InChIKey
GTEPPJFJSNSNIH-UHFFFAOYSA-N- Summenformel
- C22H34ClN3O2
- Durchschnittliche Molmasse
- 408 g/mol
- Monoisotopische Masse
- 407,233955
Überblick
Bidisomide is a member of acetamides.
Namen und Bezeichner
- Bevorzugter Name
- Bidisomide
- IUPAC
- 2-[2-[acetyl(propan-2-yl)amino]ethyl]-2-(2-chlorophenyl)-4-piperidin-1-ylbutanamide
- Englischer Name
- Bidisomide
- Summenformel
- C22H34ClN3O2
- Molmasse
- 407.97726
Namen und Synonyme
BIDISOMIDE116078-65-0BidisomidaSC-40230BidisomidumSC 402302X3Z153A4ODTXSID60869599alpha-(2-(acetyl(1-methylethyl)amino)ethyl)-alpha-(2-chlorophenyl)-1-piperidinebutanamidealpha-[2-[acetyl(1-methylethyl)amino]ethyl]-alpha-(2-chlorophenyl)-1-piperidinebutanamideRefChem:917175DTXCID70817561
Weitere Namen anzeigen
Brn 6536016Bidisomide, 10 mM in DMSO(αR)-α-[2-(Acetylisopropylamino)ethyl]-α-(2-chlorophenyl)-1-piperidinebutanamide(αS)-α-[2-(Acetylisopropylamino)ethyl]-α-(2-chlorophenyl)-1-piperidinebutanamide
103810-45-32-[2-[acetyl(propan-2-yl)amino]ethyl]-2-(2-chlorophenyl)-4-piperidin-1-ylbutanamideSC40230Bidisomide (+-)-Bidisomide [USAN:INN]Bidisomidum [INN-Latin]Bidisomida [INN-Spanish]C22H34ClN3O2
Datenbank-Bezeichner
- CAS
116078-65-0- PubChem CID
- 59798
- DTXSID
DTXSID60869599- ChEMBL
CHEMBL305745- ChEBI
CHEBI:135658- UNII
- 2X3Z153A4O
- Nikkaji
- J444.068D
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 3,1
- Polarare Oberfläche (TPSA)
- 66,6 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 9
- Schwere Atome
- 28
- Formalladung
- 0
- Komplexität
- 522
Physikochemische Eigenschaften
- Schmelzpunkt
- 140 · 140-141°
- storage temp.
- -20 °C · Store at -20°C
- Löslichkeit
- Soluble in DMSO
- Aggregatzustand
- Solid
- Farbe
- Off-white to light yellow
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Anwendungen
VerwendenCardiac depressant (anti-arrhythmic).
Anbieter11 Anbieter
Aladdin Scientific[email protected]
北京博奥森生物技术有限公司400-901-9800 18611424007 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
TargetMol中国（陶术生物）4008200310 15002144251 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
北京新研汇医药研发有限公司13969155946 · [email protected]
上海阿摩尔生物科技有限公司13370042665 18916960931 · [email protected]
Zugehörige Reaktionen
3
Notizen zur Verbindung
Wird geladen…